Eroboghene E. Ubogu

3.1k total citations
72 papers, 2.0k citations indexed

About

Eroboghene E. Ubogu is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Eroboghene E. Ubogu has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Neurology, 25 papers in Cellular and Molecular Neuroscience and 15 papers in Neurology. Recurrent topics in Eroboghene E. Ubogu's work include Peripheral Neuropathies and Disorders (23 papers), Hereditary Neurological Disorders (14 papers) and Nerve injury and regeneration (14 papers). Eroboghene E. Ubogu is often cited by papers focused on Peripheral Neuropathies and Disorders (23 papers), Hereditary Neurological Disorders (14 papers) and Nerve injury and regeneration (14 papers). Eroboghene E. Ubogu collaborates with scholars based in United States, United Kingdom and Japan. Eroboghene E. Ubogu's co-authors include Richard M. Ransohoff, Nejla Yosef, Shumei Man, Richard M. Ransohoff, Michael Cossoy, Barbara Tucky, Melissa K. Callahan, Osama O. Zaidat, Katherine Williams and Sharon Chiang and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Eroboghene E. Ubogu

69 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eroboghene E. Ubogu United States 27 574 545 526 338 314 72 2.0k
Pasquale Annunziata Italy 24 410 0.7× 337 0.6× 391 0.7× 260 0.8× 345 1.1× 62 1.6k
Saud Sadiq United States 32 971 1.7× 702 1.3× 289 0.5× 351 1.0× 880 2.8× 85 2.8k
Yuji Nakatsuji Japan 28 578 1.0× 416 0.8× 417 0.8× 470 1.4× 904 2.9× 94 2.3k
B. Tavolato Italy 29 870 1.5× 485 0.9× 469 0.9× 447 1.3× 512 1.6× 79 2.5k
Hitoshi Kikuchi Japan 24 1.0k 1.8× 283 0.5× 408 0.8× 253 0.7× 673 2.1× 82 2.3k
Jiangkai Lin China 25 308 0.5× 422 0.8× 487 0.9× 374 1.1× 581 1.9× 54 2.0k
Stefanie Küerten Germany 26 298 0.5× 379 0.7× 359 0.7× 725 2.1× 512 1.6× 106 2.1k
Kerstin Göbel Germany 26 281 0.5× 308 0.6× 547 1.0× 441 1.3× 652 2.1× 60 2.1k
Ian Sutton Australia 20 814 1.4× 312 0.6× 135 0.3× 542 1.6× 352 1.1× 43 2.0k
Tine V. Karlsen Norway 17 498 0.9× 772 1.4× 419 0.8× 302 0.9× 349 1.1× 35 2.1k

Countries citing papers authored by Eroboghene E. Ubogu

Since Specialization
Citations

This map shows the geographic impact of Eroboghene E. Ubogu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eroboghene E. Ubogu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eroboghene E. Ubogu more than expected).

Fields of papers citing papers by Eroboghene E. Ubogu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eroboghene E. Ubogu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eroboghene E. Ubogu. The network helps show where Eroboghene E. Ubogu may publish in the future.

Co-authorship network of co-authors of Eroboghene E. Ubogu

This figure shows the co-authorship network connecting the top 25 collaborators of Eroboghene E. Ubogu. A scholar is included among the top collaborators of Eroboghene E. Ubogu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eroboghene E. Ubogu. Eroboghene E. Ubogu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tavares‐Ferreira, Diana, Juliet M. Mwirigi, Stephanie Shiers, et al.. (2025). Cell and molecular profiles in peripheral nerves shift toward inflammatory phenotypes in diabetic peripheral neuropathy. Journal of Clinical Investigation. 135(20).
2.
Yadav, Dinesh Kumar, et al.. (2024). A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo. Vascular Pharmacology. 155. 107369–107369. 1 indexed citations
3.
Haque, Md. Areeful, Ronnie The Phong Trinh, Eroboghene E. Ubogu, et al.. (2023). Fibroblast-derived PI16 sustains inflammatory pain via regulation of CD206+ myeloid cells. Brain Behavior and Immunity. 112. 220–234. 15 indexed citations
4.
McLean, John W., Julie A. Wilson, Andrew J. Bean, et al.. (2022). Disruption of Endosomal Sorting in Schwann Cells Leads to Defective Myelination and Endosomal Abnormalities Observed in Charcot-Marie-Tooth Disease. Journal of Neuroscience. 42(25). 5085–5101. 3 indexed citations
5.
Nozaki, Kenkichi, et al.. (2022). A Novel Dynamin 2 Mutation Causing Dominant Intermediate Charcot-Marie-Tooth Neuropathy: Case Report. Journal of Investigative Medicine High Impact Case Reports. 10. 1615965545–1615965545. 1 indexed citations
6.
Kazamel, Mohamed, Michael A. Lopez, Martina Bebin, et al.. (2020). Fibulin-5 mutation featuring Charcot-Marie-Tooth disease, joint hyperlaxity, and scoliosis. Neurology Genetics. 6(4). e476–e476. 1 indexed citations
7.
Ubogu, Eroboghene E., et al.. (2019). In situ molecular characterization of endoneurial microvessels that form the blood‐nerve barrier in normal human adult peripheral nerves. Journal of the Peripheral Nervous System. 24(2). 195–206. 12 indexed citations
8.
Helton, E. Scott, Ping Zhou, Xavier d’Anglemont de Tassigny, et al.. (2018). Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy. Tissue Barriers. 6(2). 1–22. 15 indexed citations
9.
Ubogu, Eroboghene E., et al.. (2018). GDNF enhances human blood-nerve barrier function in vitro via MAPK signaling pathways. Tissue Barriers. 6(4). 1–22. 11 indexed citations
10.
Helton, E. Scott, et al.. (2017). The Human Blood-Nerve Barrier Transcriptome. Scientific Reports. 7(1). 17477–17477. 30 indexed citations
11.
Ubogu, Eroboghene E.. (2015). Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention. Acta Neuropathologica. 130(4). 445–468. 62 indexed citations
13.
Ubogu, Eroboghene E.. (2013). Chemokine-Dependent Signaling Pathways in the Peripheral Nervous System. Methods in molecular biology. 1013. 17–30. 8 indexed citations
14.
Ubogu, Eroboghene E.. (2013). The Molecular and Biophysical Characterization of the Human Blood-Nerve Barrier: Current Concepts. Journal of Vascular Research. 50(4). 289–303. 45 indexed citations
15.
Ubogu, Eroboghene E.. (2011). Chemokine Receptors as Specific Anti-Inflammatory Targets in Peripheral Nerves. Endocrine Metabolic & Immune Disorders - Drug Targets. 11(2). 141–153. 13 indexed citations
17.
Man, Shumei, Eroboghene E. Ubogu, Katherine Williams, et al.. (2008). Human Brain Microvascular Endothelial Cells and Umbilical Vein Endothelial Cells Differentially Facilitate Leukocyte Recruitment and Utilize Chemokines for T Cell Migration. SHILAP Revista de lepidopterología. 2008. 1–8. 85 indexed citations
18.
Ubogu, Eroboghene E., Melissa K. Callahan, Barbara Tucky, & Richard M. Ransohoff. (2006). CCR5 expression on monocytes and T cells: Modulation by transmigration across the blood–brain barrier in vitro. Cellular Immunology. 243(1). 19–29. 49 indexed citations
19.
Ubogu, Eroboghene E., Stephen M. Sagar, Alan J. Lerner, et al.. (2003). Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy & Behavior. 4(1). 70–75. 79 indexed citations
20.
Ubogu, Eroboghene E. & Henry J. Kaminski. (2001). The preferential involvement of extraocular muscles by myasthenia gravis. Neuro-Ophthalmology. 25(4). 219–228. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026